.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Professor Konstantin M. J. Sparrer

Ulm / DE

Ulm University Medical Center

Vorsitz

28.03.2024
11:00 – 12:30
Workshop
Host cell factors 2
Lecture hall 2

Speaker

26.03.2024
14:06 – 14:26 20 Min. 0 Min.
Talk
Presentation Loeffler Frosch Award 2024

Weitere Beteiligungen

25.03.2024
Poster
P 093
Inhibition and specific targeting of infected cells by VSV particles carrying viral receptors
Antiviral therapy and resistance
25.03.2024
Poster
P 086
Discovery of novel autophagy inducing anti-viral peptides derived from the human peptidome
Antiviral therapy and resistance
25.03.2024
Poster
P 078
Preclinical development of host-directed dual-target small molecule inhibitors as broad-spectrum antivirals
Antiviral therapy and resistance
25.03.2024
Poster
P 222
Discovery of novel antiviral factors by SIVcpz-guided CRISPR screens
Host cell factors
25.03.2024
Poster
P 219
Restriction of common cold Coronaviruses by SERINC proteins
Host cell factors
25.03.2024
Poster
P 334
Identification and verification of Interferon type II-specific factors inhibiting SARS-CoV-2
Innate immunity
25.03.2024
Poster
P 301
STAT1/5B signaling links interferon signaling and autophagy
Innate immunity
25.03.2024
Poster
P 290
Replication competent HIV-guided CRISPR screen identifies novel antiviral factor
Innate immunity
25.03.2024
Poster
P 419
Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization
Respiratory viruses
27.03.2024
08:45 – 09:00 12 Min. 3 Min.
Abstract talk
O 059
Sensing of HIV-1 infection by RLRs is counteracted by Nef-mediated actin stabilization
Innate immunity
28.03.2024
09:00 – 09:15 12 Min. 3 Min.
Abstract talk
O 088
Mutation T9I in envelope conveys autophagy resistance of SARS-CoV-2 Omicron
Respiratory viruses
28.03.2024
09:15 – 09:30 12 Min. 3 Min.
Abstract talk
O 077
Tackling chronic inflammation by virus-inspired strategies
Innate immunity
28.03.2024
09:30 – 09:45 12 Min. 3 Min.
Abstract talk
O 078
Extracellular vesicles in body fluids expose phosphatidylserine to mimic viral membranes and inhibit infection providing an innate barrier for transmission
Innate immunity